The World Health Organization (WHO) clearly pointed out in its guiding document on immune desensitization therapy that "immune desensitization therapy is the only fundamental treatment that can completely treat allergic diseases".
1: konka's product components are extracted according to the supercritical bioengineering technology of James D. Watson DNA, the discoverer of DNA double helix structure, and the purity is over 98%.
2: 40 kinds of natural polyphenols are compounded, which has broad-spectrum desensitization effect and overcomes the singleness of traditional allergy treatment methods.
3. The standardized allergy treatment plan organized by the international allergy research authority can automatically and specifically search for allergens, repair damaged cells, restore body functions, and quickly and effectively eliminate various allergic symptoms. One allergen can be removed in 15 days.
4. The crystallization of decades of clinical research by Konka and American Allergy Research Center. Obtained FDA registration number, which is a stable and mature product in European and American markets. Millions of patients in Europe and America have witnessed the curative effect, which is safe and reliable for 50 years without any side effects.
5. Quickly and effectively remove urticaria, eczema, allergic purpura, allergic conjunctivitis, cosmetic allergy, facial redness, food allergy, seafood allergy, skin allergy, facial allergy, alcohol allergy, drug allergy, plant allergy, chemical allergy, ultraviolet allergy, metal allergy, alcohol allergy, hormone allergy, allergic asthma, allergic pharyngitis and other allergic symptoms. Clinical average 15 days can get rid of an allergen, and at the same time, it has excellent curative effect on chronic inflammation such as gastrointestinal inflammation and chronic pharyngitis and non-bacterial inflammation such as rheumatism and rheumatoid arthritis.
European and American authorities confirm safety.
Konka total immune desensitization factors are considered to be safe because they are ubiquitous in many foods. Konka total immune desensitization factor has been widely used in Europe for decades, and it has a history of several years in the United States, and no side effects have been reported everywhere. In addition, Pasteur Institute in Lyon, France and Cytotest Cell Research in Germany have both done experiments on Konka's total immune desensitization factor, which is non-toxic, non-carcinogenic, non-teratogenic and non-antigenic. The results showed that Kangjia total immune desensitization factor was safe and reliable. American patent. No.3436407 also records that the above test results are true.
So far, no drugs that may interact with anthocyanins before OPC have been found, and there is no conflict with other drugs. Konka total immune desensitization factor has no side effects.
Toxicology reference data in August 7, 2000: 48 (2-3): 187- 197. This comprehensive report was published in the journal Toxicology in August 2000, and on August 7, 2000: 48 (2-3):187.
French patent
French patent for extraction (patent number 1 427, 100) and vascular protection (4482M). It is mentioned in the patent that it can maintain the tissue and function of venous-lymphatic system.
Symptoms related to venous lymphatic system insufficiency, including edema and functional problems:
Heavy legs, paresthesia, cramps, pain and uneasiness.
Skin capillaries are fragile and allergic.
Ecchymosis, allergic purpura
Adjuvant treatment of retinal and coronary circulation problems
Related symptoms of hemorrhoid attack
British patent
PatentNo. 1092267 was obtained in Britain. The patent describes the extraction method of this product and its protective effect on blood vessels, especially capillaries. The patents in France, Britain and the United States explain the influence caused by insufficient capillaries:
purpura
Allergy (urticaria, eczema, Quicke's edema, sweat blister)
skin disease
cellulitis
Vascular diseases caused by hypertension
diabetic retinopathy (DR)
Capillary fragility caused by renal insufficiency, hepatic insufficiency and infectious diseases
Hemorrhoid rupture
Capillary fragility caused by anticoagulant therapy
Various forms of edema, such as heavy feeling in the legs.
Phlebitis caused by varicose ulcer
Pleural effusion and pleurisy in patients with heart disease
Arterial adventitiitis
U.S.P.
U.S. Patent-Free Radical Scavenger Effect (No.4,698,360) The present invention provides a method for preventing and resisting the biological effects of free radical damage to tissues and organs of warm-blooded animals (especially humans), namely brain atrophy, arteriosclerosis, myocardial infarction, cerebral infarction, tumor formation, allergic inflammation, ischemia, synovial fluid change and collagen degradation. The method gives animals or people a substance containing proanthocyanidins (OPC) extracted from Pinaceae plants, and has the function of scavenging free radicals.
Original abstract
The invention provides a method for preventing and counteracting the harmful biological effects of free radicals in warm-blooded animals, especially human bodies, namely brain degeneration, hypoxia after atherosclerosis, heart or cerebral infarction, tumor promotion, inflammation, ischemia, synovial fluid change, collagen degradation and the like. The Opera House